SCHEMBL3165360

SCHEMBL3165360

CC(=O)NCCNc1cc(NC(=O)C(=O)N2CCN(c3ccccc3C#N)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PHGDH O43175 1/20 0.43
▸ CYP1A2 P05177 3/20 0.42
▸ CYP3A4 P08684 3/20 0.42
▸ CYP2D6 P10635 2/20 0.42
▸ CLK4 Q9HAZ1 2/20 0.42
▸ USP2 O75604 1/20 0.42
▸ DRD2 P14416 5/20 0.41
▸ DRD4 P21917 5/20 0.41
▸ ADORA2A P29274 3/20 0.40
▸ ADORA1 P30542 3/20 0.40
▸ ADORA2B P29275 2/20 0.40
▸ ADORA3 P0DMS8 2/20 0.40
▸ DRD3 P35462 4/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ THPO P40225 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ GMNN O75496 1/20 0.38
▸ LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3156223 0.89 KMT2A (0.42) CYP1A2CYP3A4CYP2D6CLK4DRD2
SCHEMBL3164424 0.89 ADORA2A (0.41) CYP1A2CYP3A4CYP2D6CLK4ADORA2A
SCHEMBL3170204 0.88 KMT2A (0.43) USP2DRD2ADORA2AADORA1ADORA2B
SCHEMBL3161165 0.88 ABCG2 (0.45) CYP1A2CYP3A4CYP2D6CLK4USP2
SCHEMBL3166495 0.87 SLC1A2 (0.44) CYP1A2CYP3A4CYP2D6CLK4USP2
SCHEMBL3175718 0.87 DRD4 (0.51) CYP1A2CYP3A4CYP2D6CLK4USP2
SCHEMBL3175820 0.87 MEN1 (0.46) PHGDHDRD2DRD4DRD3ALDH1A1
SCHEMBL3175769 0.86 ADORA2A (0.45) CYP1A2CYP3A4CYP2D6CLK4USP2
SCHEMBL3170498 0.85 TSHR (0.41) CYP1A2CYP3A4CLK4DRD2DRD4
SCHEMBL3155892 0.85 ADORA2A (0.46) CYP1A2CYP3A4CYP2D6CLK4USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback